Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00745056 · ClinicalTrials.gov registry record
Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study)
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 2,922
- Enrollment target
NCT00745056: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00745056 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 2,922 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00745056 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 2,922 participants
- Enrollment target
Study Summary
This is a prospective, observational study of the cohort of older post-menopausal participants in the WHI Memory Study, a sub-cohort of participants in the WHI Hormone Trials. Annual cognitive assessments and ascertainment of cognitive impairment enable the continued monitoring of long-term effects of randomization to HT on cognition and identification of predictors of cognitive vulnerability and resilience in older women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,922 participants |
| Start Date | 2008-09-11 |
| Est. Completion | 2021-11-04 |
What the finished NCT00745056 record still lists
NCT00745056 is an observational study that tracks outcomes without assigning an intervention. Its 2,922 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00745056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00745056 about?
NCT00745056 is a clinical study titled "Examining the Relationship Between Hormone Therapy (HT) and Cognitive Function (The WHIMS-ECHO Study)". This is a prospective, observational study of the cohort of older post-menopausal participants in the WHI Memory Study, a sub-cohort of participants in the WHI Hormone Trials. Annual cognitive assessments and ascertainment of cognitive impairment enable the continued monitoring of long-term effects ...
What is the current status of trial NCT00745056?
This trial is currently completed. The enrollment target is 2,922 participants. The study started on 2008-09-11. Estimated completion is 2021-11-04.
Who is sponsoring clinical trial NCT00745056?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
- NCT03331380 · 2,950 participants · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI